Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended...

Area of Science:

• Pharmacokinetics and Drug Delivery
• Gastrointestinal Physiology
• Pharmaceutical Sciences

Background:

• Food intake significantly impacts gastrointestinal conditions, influencing drug dissolution and absorption.
• Extended-release drug formulations can exhibit variable performance based on food consumption.
• Understanding the food effect is crucial for optimizing drug delivery and therapeutic outcomes.

Purpose of the Study:

• To investigate the dosage form-dependent food effect for two nifedipine extended-release formulations.
• To evaluate the utility of biorelevant dissolution methods in predicting in vivo performance.
• To compare the performance of USP apparatus III and IV in detecting food effects.

Main Methods:

• Two nifedipine extended-release formulations (Adalat® XL 60mg, Adalat® Eins 30mg) were tested using biorelevant dissolution media.
• Dissolution tests were conducted using USP apparatus III and IV under simulated fed and fasted states.
• In vitro data were correlated with in vivo data using deconvolution-based in vitro-in vivo correlation (IVIVC) models.

Main Results:

• Standard quality control dissolution methods overestimated nifedipine dissolution rates.
• USP apparatus III with biorelevant media successfully described the food effect for both formulations.
• USP apparatus IV failed to detect the positive food effect for the matrix-type nifedipine formulation.

Conclusions:

• Biorelevant dissolution methods are valuable tools for pharmaceutical formulation development.
• These in vitro methods can qualitatively predict in vivo drug behavior, including food effects.
• Accurate prediction of food effects aids in designing effective extended-release drug products.